- Home
- ARAY vs MSD Comparison
ARAY vs MSD Comparison
Compare ARAY & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- MSD
- Stock Information
- Founded
- ARAY 1990
- MSD 1993
- Country
- ARAY United States
- MSD United States
- Employees
- ARAY N/A
- MSD N/A
- Industry
- ARAY Medical/Dental Instruments
- MSD Trusts Except Educational Religious and Charitable
- Sector
- ARAY Health Care
- MSD Finance
- Exchange
- ARAY Nasdaq
- MSD Nasdaq
- Market Cap
- ARAY 180.0M
- MSD 161.1M
- IPO Year
- ARAY 2007
- MSD N/A
- Fundamental
- Price
- ARAY $2.24
- MSD $7.92
- Analyst Decision
- ARAY Strong Buy
- MSD
- Analyst Count
- ARAY 1
- MSD 0
- Target Price
- ARAY $9.00
- MSD N/A
- AVG Volume (30 Days)
- ARAY 669.1K
- MSD 70.2K
- Earning Date
- ARAY 01-29-2025
- MSD 01-01-0001
- Dividend Yield
- ARAY N/A
- MSD 11.26%
- EPS Growth
- ARAY N/A
- MSD N/A
- EPS
- ARAY N/A
- MSD N/A
- Revenue
- ARAY $444,204,000.00
- MSD N/A
- Revenue This Year
- ARAY $6.64
- MSD N/A
- Revenue Next Year
- ARAY $5.69
- MSD N/A
- P/E Ratio
- ARAY N/A
- MSD N/A
- Revenue Growth
- ARAY N/A
- MSD N/A
- 52 Week Low
- ARAY $1.40
- MSD $6.11
- 52 Week High
- ARAY $2.99
- MSD $7.46
- Technical
- Relative Strength Index (RSI)
- ARAY 60.03
- MSD 61.07
- Support Level
- ARAY $2.04
- MSD $7.56
- Resistance Level
- ARAY $2.34
- MSD $7.97
- Average True Range (ATR)
- ARAY 0.15
- MSD 0.13
- MACD
- ARAY 0.03
- MSD 0.05
- Stochastic Oscillator
- ARAY 82.76
- MSD 87.73
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About MSD Morgan Stanley Emerging Markets Debt Fund Inc.
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.